1015-89-0 | 6(5H)-Phenanthridinone

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$7.00	$5.00
5g	98%	in stock	$18.00	$13.00
10g	98%	in stock	$35.00	$25.00
25g	98%	in stock	$46.00	$33.00
100g	98%	in stock	$148.00	$103.00
500g	98%	in stock	$523.00	$366.00

Description

• Catalog Number: AA05803
• Chemical Name: 6(5H)-Phenanthridinone
• CAS Number: 1015-89-0
• Molecular Formula: C13H9NO
• Molecular Weight: 195.2167
• MDL Number: MFCD00004988
• SMILES: O=c1[nH]c2ccccc2c2c1cccc2

Computed Properties

• Complexity: 263
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 15
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• XLogP3: 2.5

Upstream Synthesis Route

Born from the fusion of phenanthrene and pyridine, Phenanthridin-6(5H)-one is a versatile compound that finds its predominant role in chemical synthesis. Its unique structure provides a solid foundation for creating a variety of complex organic molecules through diverse chemical reactions. In the realm of organic synthesis, Phenanthridin-6(5H)-one serves as a valuable building block, offering a structural scaffold that can be functionalized and modified to yield a wide range of derivatives with different properties and applications. Whether it is in the development of pharmaceuticals, agrochemicals, or materials science, the strategic incorporation of Phenanthridin-6(5H)-one into synthetic schemes enables chemists to access novel compounds and unlock new pathways towards innovative solutions.

Literature

• Stereoselective synthesis of functionalised carbocyclic amides: construction of the syn-(4aS,10bS)-phenanthridone skeleton.

  Organic & biomolecular chemistry 20120521

• Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.

  Nature biotechnology 20120219

• Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride.

  Journal of enzyme inhibition and medicinal chemistry 20111201

• PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.

  Multiple sclerosis (Houndmills, Basingstoke, England) 20110701

• Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids.

  Archives of pharmacal research 20110701

• Effects of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose)polymerase-1 activity (PARP-1), on locomotor networks of the rat isolated spinal cord.

  Cellular and molecular neurobiology 20110501

• One-pot formation of C-C and C-N bonds through palladium-catalyzed dual C-H activation: synthesis of phenanthridinones.

  Angewandte Chemie (International ed. in English) 20110207

• A highly sensitive RP-HPLC-fluorescence method to study aldehyde oxidase activity.

  Journal of AOAC International 20110101

• Molecular Mechanisms Underlying Cell Death in Spinal Networks in Relation to Locomotor Activity After Acute Injury in vitro.

  Frontiers in cellular neuroscience 20110101

• Hepatoprotective effects of select water-soluble PARP inhibitors in a carbon tetrachloride model.

  International journal of critical illness and injury science 20110101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

  Nature chemical biology 20091001

• Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors.

  Bioorganic & medicinal chemistry letters 20090501

• Attenuation of bromobenzene-induced hepatotoxicity by poly(ADP-ribose) polymerase inhibitors.

  Research communications in molecular pathology and pharmacology 20090101

• Chronic exposure of the oligochaete Lumbriculus variegatus to polycyclic aromatic compounds (PACs): bioavailability and effects on reproduction.

  Environmental science & technology 20080501

• A novel spectrophotometric method for determination of kinetic constants of aldehyde oxidase using multivariate calibration method.

  Journal of biochemical and biophysical methods 20080424

• Total synthesis of 7-deoxypancratistatin-1-carboxaldehyde and carboxylic acid via solvent-free intramolecular aziridine opening: phenanthrene to phenanthridone cyclization strategy.

  Organic letters 20080207

• Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase.

  Bioorganic & medicinal chemistry letters 20071115

• A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.

  Journal of immunology (Baltimore, Md. : 1950) 20070701

• Synthesis of some members of the hydroxylated phenanthridone subclass of the Amaryllidaceae alkaloid family.

  The Journal of organic chemistry 20070330

• Effects of proximity on the relaxation dynamics of flindersine and 6(5H)-phenanthridinone.

  The journal of physical chemistry. A 20070118

• 6,(5H)-phenanthridinone protects against carbon tetrachloride-induced cytotoxicity in human HepG2 cells.

  Research communications in molecular pathology and pharmacology 20070101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.

  Journal of medicinal chemistry 20050811

• Fungal biotransformation of benzo[f]quinoline, benzo[h]quinoline, and phenanthridine.

  Applied microbiology and biotechnology 20050501

• The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.

  Toxicology and applied pharmacology 20050101

• Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1.

  The Biochemical journal 20040815

• An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.

  Analytical biochemistry 20040301

• Hepatoprotective effects of 6(5H)-phenanthridinone from chemical-induced centrilobular necrosis.

  Research communications in molecular pathology and pharmacology 20040101

• Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries.

  Bioorganic & medicinal chemistry 20030815

• Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.

  Journal of medicinal chemistry 20030703

• Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.

  The Journal of pharmacology and experimental therapeutics 20030601

• Nicotinamide is a potent inhibitor of proinflammatory cytokines.

  Clinical and experimental immunology 20030101

• Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats.

  British journal of pharmacology 20021101

• Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.

  Critical care medicine 20020501

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• A new strategy towards the total synthesis of phenanthridone alkaloids: synthesis of (+)-2,7-dideoxypancratistatin as a model study.

  Chemical communications (Cambridge, England) 20020321

• Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.

  Cell death and differentiation 20010901

• Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors.

  Bioorganic & medicinal chemistry letters 20010709

• Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.

  Cancer research 20010515

• Comparative metabolism of phenanthridine by carp (Cyprinus carpio) and midge larvae (Chironomus riparius).

  Environmental pollution (Barking, Essex : 1987) 20010101

• Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase.

  Proceedings of the National Academy of Sciences of the United States of America 19960514

• N-acetylcysteine protects lymphocytes from nitrogen mustard-induced apoptosis.

  Biochemical pharmacology 19960503